Fecal occult blood testing, a patient-administered test that is much less expensive than a colonoscopy, is a valid option for early detection of colon cancer, according to a report in the Canadian ...

After a maximum follow-up of 14 years, the mean screening participation rate was 63.3%. Those who underwent early screening had reduced risk for colorectal cancer mortality and excess mortality.

June 8, 2009 (Chicago, Illinois) – Detection of "long DNA" in the stool, when combined with fecal occult blood testing, detects colorectal cancers with a specificity of 90%. This approach is "among ...

A new study found fecal immunochemical testing is more effective than guaiac fecal occult blood testing and is often performed at a lower cost, according to findings published by the Journal of the ...

UCLA research finds that fewer than one in four eligible younger adults completed colorectal cancer screenings after the United States Preventive Services Task Force (USPSTF) lowered the recommended ...

The number of colonoscopies needed to detect one person with advanced neoplasia was 5.1 for guaiac-positive patients but only 2.7 for immunochemical-test–positive patients. Colonoscopy revealed ...

Credit: Reese Pharmaceutical. ColoTest is designed to detect blood in stool, which may be an early indication for colorectal cancer, diverticulitis, gastrointestinal disorders, colitis or polyps.

The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

About The Study: This study of routine screening with fecal occult blood testing found a 14% decrease in colorectal cancer mortality associated with screening. The true association of screening with ...

Stool-based tests for colorectal cancer (CRC) screening show no significant difference in detecting advanced neoplasia overall, but for advanced serrated lesions specifically, the multitarget stool ...